20-F/A

FORM 20-F/A

Company: Galmed Pharmaceuticals Ltd.
Filed: June 23, 2017
Period of Report: December 31, 2015
Accession Number: 0001144204-17-033833

View Document ↗ View on SEC.gov ↗